Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Design Therapeutics Inc
(NQ:
DSGN
)
5.040
-0.320 (-5.97%)
Streaming Delayed Price
Updated: 11:43 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Design Therapeutics Inc
< Previous
1
2
3
Next >
Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
August 05, 2024
From
Design Therapeutics, Inc.
Via
GlobeNewswire
The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
May 22, 2024
Biotechs can see triple-digit returns or dramatic losses but these Piper Sandler stocks have the potential to achieve them.
Via
InvestorPlace
DSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024
May 08, 2024
DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
May 08, 2024
From
Design Therapeutics, Inc.
Via
GlobeNewswire
Earnings Preview For Design Therapeutics
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 07, 2024
Via
Benzinga
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024
From
Design Therapeutics, Inc.
Via
GlobeNewswire
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
March 26, 2024
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023
March 19, 2024
DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
March 19, 2024
From
Design Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 19, 2024
March 19, 2024
Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.
Via
Benzinga
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
March 12, 2024
From
Design Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 09, 2024
Via
Benzinga
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
November 13, 2023
From
Design Therapeutics, Inc.
Via
GlobeNewswire
Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
August 31, 2023
The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch
August 17, 2023
All three leading U.S. stock indices — the S&P 500, Nasdaq 100, and Russell 2000 — have simultaneously breached a crucial technical support level this week.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments
August 15, 2023
RBC Capital Market downgraded Design Therapeutics Inc (NASDAQ: DSGN) from Outperform to Sector Perform with a price target of $7,
Via
Benzinga
Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher
August 15, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded down 0.82% to 35,017.95 while the NASDAQ fell 0.77% to 13,682.54. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of Design Therapeutics Are Plummeting on Tuesday
August 15, 2023
The biotech company released phase 1 trial details regarding a Friedreich ataxia therapy.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 15, 2023
Via
Benzinga
Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
August 15, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 90 points on Tuesday. The Dow traded down 0.75% to 35,042.16 while the NASDAQ fell 0.66% to 13,697.15. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
Dow Falls Over 200 Points; US Retail Sales Top Expectations
August 15, 2023
U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.67% to 35,069.60 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 15, 2023
Via
Benzinga
Why Is Design Therapeutics Stock Moving Lower Today?
August 15, 2023
Design Therapeutics Inc (NASDAQ: DSGN) reported initial results from the company's Phase 1 multiple-ascending dose (MAD) clinical trial of DT-216 in
Via
Benzinga
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
August 15, 2023
Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with...
Via
Benzinga
Exposures
Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 15, 2023
Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!
Via
InvestorPlace
Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 15, 2023
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 14, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.